Key result
Modulating inflammation and the immune system presents a promising therapeutic avenue for reducing cardiovascular events, as highlighted by recent clinical trials and basic research.
Announces a new journal collection focused on immunity and inflammation in cardiovascular disease.
Recent studies have developed our understanding of the role of the immune system and inflammation in Cardiovascular Disease (CVD), opening new avenues for risk stratification and therapeutic intervention. However, gaps in our knowledge remain. To address this issue, BMC Cardiovascular Disorders has launched a Collection on "Immunity and Inflammation in Cardiovascular Disorders".
No takes yet. Share an insight, caveat, or question.
Boyalla et al. (2023) conducted an editorial in Cardiovascular Disease. Modulating inflammation and the immune system presents a promising therapeutic avenue for reducing cardiovascular events, as highlighted by recent clinical trials and basic research.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: